Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/18/2003US6534058 Anti-C5 monoclonal antibodies
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003US6534018 Precisely controlled in line metering system for mixing suspensions, emulsions, ointments and creams
03/18/2003US6534009 Method and apparatus for frequency thermal control
03/18/2003US6533914 Microfabricated injector and capillary array assembly for high-resolution and high throughput separation
03/18/2003CA2194153C Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing
03/18/2003CA2190588C Pteridine nucleotide analogs as fluorescent dna probes
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2126356C Human serum-albumin, preparation and use thereof
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2104022C High sulfur seed protein gene and method for increasing the sulfur amino acid content of plants
03/18/2003CA2092519C Synthetic polypeptides as inhibitors of hiv-1
03/18/2003CA2085134C Gdf-1
03/18/2003CA2067194C Cell-free synthesis and isolation of novel genes and polypeptides
03/18/2003CA2045175C Production of proteins using homologous recombination
03/18/2003CA2044115C Method for the quantitative determination of dna sequences
03/18/2003CA2005016C Dna fragment containing promoter region for human polypeptide chain elongation factor-1.alpha. and expression plasmid containing the dna fragment
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021266A1 The great gene and protein
03/13/2003WO2003021265A1 Genetic construct intracellular monitoring system
03/13/2003WO2003021261A2 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
03/13/2003WO2003021256A1 Method for identifying polymorphic markers in a population
03/13/2003WO2003020986A1 Method of isolating cells and uses thereof
03/13/2003WO2003020985A1 Detection of genetic sequences using a bipartite probe
03/13/2003WO2003020981A1 Nucleic acid archiving
03/13/2003WO2003020979A1 Methods for preparing nucleic acid samples
03/13/2003WO2003020978A1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group
03/13/2003WO2003020974A2 Methods for detecting dna originating from different individuals in one sample
03/13/2003WO2003020972A1 Molecular identification of staphylococcus-type bacteria
03/13/2003WO2003020970A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
03/13/2003WO2003020967A1 A method for the determination of multiple analytes
03/13/2003WO2003020965A2 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
03/13/2003WO2003020962A2 Method of identifying glycosyl transferase binding compounds
03/13/2003WO2003020957A2 Use of fructose-1,6-bisphosphate aldolase for identifying novel substances having a fungicidal action
03/13/2003WO2003020956A2 Nucleid acid compositions conferring herbicide resistance
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020952A2 Affinity-shifted probes for quantifying analyte polynucleotides
03/13/2003WO2003020951A2 Identification of a novel group ii intron splicing factor
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020947A2 Mid 9002, a human sulfatase family member and uses therefor
03/13/2003WO2003020940A1 Method of modifying genome in higher plant
03/13/2003WO2003020939A1 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
03/13/2003WO2003020938A2 Method of protein production in plants
03/13/2003WO2003020937A2 Rice regulatory sequences for gene expression in defined wheat tissue
03/13/2003WO2003020936A1 Nucleic acid compositions conferring altered metabolic characteristics
03/13/2003WO2003020935A1 Control of plant flowering time by regulating the expression of phytochrome c
03/13/2003WO2003020934A1 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020933A1 Novel serine protease inhibitory protein mt0039
03/13/2003WO2003020932A1 Novel secretory proteins and dna thereof
03/13/2003WO2003020931A2 Sirna knockout assay method and constructs
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020928A2 Identification of eukaryotic internal ribosome entry site (ires) elements
03/13/2003WO2003020927A2 Creation of artificial internal ribosome entry site (ires) elements
03/13/2003WO2003020926A1 Stable episomal vectors
03/13/2003WO2003020920A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003WO2003020916A2 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
03/13/2003WO2003020915A2 Non-linear amplitude dielectrophoresis waveform for cell fusion
03/13/2003WO2003020914A2 Protein phosphatase stress-related polypeptides and methods of use in plants
03/13/2003WO2003020912A2 Novel clark protein and nucleic acid molecules and uses therefor
03/13/2003WO2003020907A2 Histamine receptor h4 polynucleotides
03/13/2003WO2003020906A2 Multivalent protein conjugate with multiple ligand-binding domains of receptors
03/13/2003WO2003020905A2 Nucleic acid compositions conferring disease resistance
03/13/2003WO2003020902A2 Methods for blocking nonspecific hybridizations of nucleic acid sequences
03/13/2003WO2003020901A2 Compositions and methods relating to prostate specific genes and proteins
03/13/2003WO2003020897A2 Compositions and methods relating to ovary specific genes and proteins
03/13/2003WO2003020896A2 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
03/13/2003WO2003020895A2 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
03/13/2003WO2003020894A2 Insulin related transcription factor and uses thereof
03/13/2003WO2003020893A2 New adenovirus type 7 vectors
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020891A2 Single nucleotide amplification and detection by polymerase
03/13/2003WO2003020890A2 Genes encoding baeyer-villiger monooxygenases
03/13/2003WO2003020888A2 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof
03/13/2003WO2003020887A2 Gene identification
03/13/2003WO2003020885A2 Identification of sortase gene
03/13/2003WO2003020879A2 Cells and methods for propagating adenoviral vectors
03/13/2003WO2003020878A2 Amplification and detection reagents for hiv-1
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020873A2 Reproduction of ribonucleic acids
03/13/2003WO2003020769A1 Pemphigus monoclonal antibody
03/13/2003WO2003020767A2 Antibodies against caspase-8, their preparation and use
03/13/2003WO2003020766A1 Late gestation lung genes, fragments and uses thereof
03/13/2003WO2003020764A2 Modified factor ix
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020761A1 Modified human growth hormone
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020758A2 Cdk regulator proteins called ringo
03/13/2003WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003WO2003020756A2 Hybrid and tandem expression of neisserial proteins
03/13/2003WO2003020755A1 Mutated env gene, mutated env glycoprotein and the use thereof
03/13/2003WO2003020754A2 Inhibition of replication factor c
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
1 ... 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 ... 4023